Open AccessCOMBINED ACAMPROSATE AND NALTREXONE, WITH COGNITIVE BEHAVIOURAL THERAPY IS SUPERIOR TO EITHER MEDICATION ALONE FOR ALCOHOL ABSTINENCE: A SINGLE CENTRES' EXPERIENCE WITH PHARMACOTHERAPY
Author(s) -
Gerald F.X. Feeney,
Jason P. Connor,
Ross McD. Young,
Jane Tucker,
Annie McPherson
Publication year - 2006
Publication title -
alcohol and alcoholism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.747
H-Index - 99
eISSN - 1464-3502
pISSN - 0735-0414
DOI - 10.1093/alcalc/agl007
Subject(s) - acamprosate , naltrexone , abstinence , pharmacotherapy , alcohol dependence , psychiatry , psychology , cognitive therapy , medicine , alcohol use disorder , cognitive behavioral therapy , relapse prevention , psychotherapist , craving , alcohol , cognition , addiction , opioid , biochemistry , chemistry , receptor
To compare treatment outcomes amongst patients offered pharmacotherapy with either naltrexone or acamprosate used singly or in combination, in a 12-week outpatient cognitive behavioural therapy (CBT) programme for alcohol dependence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom